Retatrutide's Big Numbers, Appendicitis Delays, and Lean Fatty Liver

Today we cover a major new perioperative cardiology guideline, striking phase three results for the obesity drug retatrutide, a global study on appendicitis treatment delays, and a surprising diet-microbiome link during antibiotics. We also look at a new combination therapy for resistant breast cancer and new evidence on lean fatty liver disease. Plus a quick rundown of five more notable studies in oncology, nephrology, and anesthesia.